Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Hohmann

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos Neglected Tropical Diseases|December 20, 2011
In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in BangladeshAlaullah Sheikh, Richelle C Charles, Nusrat Sharmeen, et al.
Inflammatory Bowel Diseases|July 21, 2010
Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitisSundaram Ramasamy, Deanna D Nguyen, Michelle A Eston, et al.
Obstetrics and Gynecology|August 28, 2020
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)Bijan Safaee Fakhr, Steffen B Wiegand, Riccardo Pinciroli, et al.
The American Journal of Gastroenterology|June 4, 2014
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patientsColleen R Kelly, Chioma Ihunnah, Monika Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos Neglected Tropical Diseases|December 20, 2011
In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in BangladeshAlaullah Sheikh, Richelle C Charles, Nusrat Sharmeen, et al.
Inflammatory Bowel Diseases|July 21, 2010
Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitisSundaram Ramasamy, Deanna D Nguyen, Michelle A Eston, et al.
Obstetrics and Gynecology|August 28, 2020
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)Bijan Safaee Fakhr, Steffen B Wiegand, Riccardo Pinciroli, et al.
The American Journal of Gastroenterology|June 4, 2014
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patientsColleen R Kelly, Chioma Ihunnah, Monika Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Pageof 6